CSF Biomarkers Predict Gait Outcomes in Idiopathic Normal Pressure Hydrocephalus

Jacqueline A Darrow1, Alexandria Lewis1, Seema Gulyani1

  • 1Department of Neurology (JAD, AL, SG, KK, AR, AM), Johns Hopkins University School of Medicine; Department of Biostatistics (JW, YZ), Johns Hopkins University Bloomberg School of Public Health; Department of Neurosurgery (ML), and Department of Medicine (SY), Johns Hopkins University School of Medicine, Baltimore, MD.

Summary

Cerebrospinal fluid (CSF) biomarkers, including neurofilament light (NfL) and tau proteins, can predict long-term shunt surgery outcomes in idiopathic normal pressure hydrocephalus (iNPH). However, these biomarkers show limited ability to predict immediate response to CSF tap tests.

Related Concept Videos